Search Results 341-350 of 18469 for Relapse
... relapse. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...
... (relapsed) but is not resistant to bortezomib (refractory). Ixazomib citrate may stop the growth of cancer cells by blocking some of the enzymes needed for ...
ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...
Study shows drug reduces risk of relapse with neuromyelitis optica featured image. Featured News. Study shows drug reduces risk of relapse with neuromyelitis ...
Mayo Clinic researchers map prostate cancer relapse using C-11 choline PET and MRI featured. Cancer. Mayo Clinic researchers map prostate cancer relapse using C ...
Science Saturday: Genetic test solves mystery of family bleeding disorder featured image · Study shows drug reduces risk of relapse with neuromyelitis optica ...
Mayo Clinic researchers link CAR-T cell aging to cancer relapse featured image. Featured News. Mayo Clinic researchers link CAR-T cell aging to cancer relapse.
last relapse per WHO 2017 - At least 1 measurable lesion at time of enrollment - Relapsed or refractory disease after at least 2 lines of chemotherapy - ...
The purpose of this study is to determine the effectiveness and safety of JCAR017 in adult subjects with relapsed ... Patients at high risk of relapse are ...
This phase II trial is studying the side effects and how well cixutumumab works in treating patients with relapsed or refractory solid tumors. Monoclonal ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.